The content is available as a PDF (66.7 KB).
Compliance with ethics guidelines
Kaixian Chen and Hongzhuan Chen declare no conflict of interests. This manuscript does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.
References
- 1.Ni LQ, Chen LL, Huang X, Han CP, Xu JR, Zhang H, Luan X, Zhao YF, Xu JG, Yuan WA, Chen HZ. Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharma Sin B 2020; [Epub ahead of print] doi: 10.1016/j.apsb.2020.06.009 [DOI] [PMC free article] [PubMed]
- 2.Lai S, Ruktanoncchai NW, Zhou L, Prosper O, Luo W, Floyd JR, Wesolowski A, Santillana M, Zhang C, Du X, Yu H, Tatem AJ. Effect of non-pharmaceuical interventions to contain COVID-19 in China. Nature 2020; [Epub ahead of print] doi: 10.1038/s41586-020-2293-x [DOI] [PMC free article] [PubMed]
- 3.Chen S, Zhang Z, Yang J, Wang J, Zhai X, Bärnighausen T, Wang C. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet. 2020;395:1305–1314. doi: 10.1016/S0140-6736(20)30744-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Liu M, Gao Y, Yuan Y, Yang K, Shi S, Zhang J, Tian J. Efficacy and safety of integrated traditional Chinese and Western medicine for coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol Res. 2020;158:104896. doi: 10.1016/j.phrs.2020.104896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ni L, Zhou L, Zhou M, Zhao J, Wang D. Combination of western medicine and Chinese patent medicine in treating a family case of COVID-19. Front Med. 2020;14(2):210–214. doi: 10.1007/s11684-020-0757-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ye YA, G-CHAMPS Collaborative Group. Guideline-based Chinese herbal medicine treatment plus standard care for severe coronavirus disease 2019 (G-CHAMPS): evidence from China. Medrxiv 2020; doi: 10.1101/2020.03.27.20044974 [DOI] [PMC free article] [PubMed]
- 7.Wang C, Cao B, Liu QQ, Zou ZQ, Liang ZA, Gu L, Dong JP, Liang LR, Li XW, Hu K, He XS, Sun YH, An Y, Yang T, Cao ZX, Guo YM, Wen XM, Wang YG, Liu YL, Jiang LD. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med. 2011;155(4):217–225. doi: 10.7326/0003-4819-155-4-201108160-00005. [DOI] [PubMed] [Google Scholar]
- 8.Du HZ, Hou XY, Miao YH, Huang BS, Liu DH. Traditional Chinese medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP) Chin J Nat Med. 2020;18(3):206–210. doi: 10.1016/S1875-5364(20)30022-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Liu F, Jiang R, Yang X, You T, Liu X, Yang X, Bai F, Liu H, Liu X, Guddat LW, Xu W, Xiao G, Qin C, Shi Z, Jiang H, Rao Z, Yang H. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 2020; [Epub ahead of print] doi: 10.1038/s41586-020-2223-y [DOI] [PubMed]
- 10.Mani JS, Johnson JB, Steel JC, Broszczak DA, Neilsen PM, Walsh KB, Naiker M. Natural product-derived phytochemicals as potential agents against coronaviruses: a review. Virus Res. 2020;284:197989. doi: 10.1016/j.virusres.2020.197989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Li RF, Hou YL, Huang JC, Pan WQ, Ma QH, Shi YX, Li CF, Zhao J, Jia ZH, Jiang HM, Zheng K, Huang SX, Dai J, Li XB, Hou XT, Wang L, Zhong NS, Yang ZF. Lianhuaqingwen exerts antiviral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Pharmacol Res. 2020;156:104761. doi: 10.1016/j.phrs.2020.104783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Cyranoski D. China is promoting coronavirus treatments based on unproven traditional medicines. Nature 2020; [Epub ahead of print] doi: 10.1038/d41586-020-01284-x [DOI] [PubMed]